Medicine and Dentistry
Partial Nephrectomy
100%
Neoplasm
66%
Radical Nephrectomy
62%
Malignant Neoplasm
35%
Kidney Tumour
31%
Nephrectomy
29%
Kidney Function
28%
Clear Cell Renal Cell Carcinoma
28%
Renal Vein
25%
Thrombectomy
22%
Cohort Analysis
21%
Overall Survival
21%
Disease
20%
Glomerular Filtration Rate
19%
Biopsy
19%
Lymph Node
17%
Prostate Hypertrophy
17%
Natural Orifice Translumenal Endoscopic Surgery
17%
Laparoendoscopic Single Site Surgery
17%
Computer Assisted Tomography
15%
Prevalence
14%
Incision
14%
Ischemia
13%
Prostate Cancer
13%
Prostatectomy
13%
Tyrosine-Kinase Inhibitor
13%
Sunitinib
12%
Operation Duration
12%
Body Mass Index
12%
Bladder
12%
Chronic Kidney Disease
11%
Transitional Cell Carcinoma
11%
Prostate Biopsy
11%
Nephron Sparing Surgery
11%
Logistic Regression Analysis
10%
Odds Ratio
10%
Case Presentation
10%
Vein Embolism
10%
Laparoscopy
10%
Targeted Therapy
9%
Hyperlipidemia
9%
Acetylsalicylic Acid
8%
Prostate Cancer Staging
8%
Erectile Dysfunction
8%
Masturbation
8%
Leiomyomatosis
8%
Genetic Screening
8%
Clinical Genetics
8%
Preoperative Chemotherapy
8%
Fumarate Hydratase
8%
Keyphrases
Partial Nephrectomy
42%
Radical Nephrectomy
34%
RENAL Nephrometry Score
21%
Laparoendoscopic Single-site Surgery
18%
Cohort Analysis
17%
Cytoreductive Nephrectomy
17%
Renal Vein
17%
Laparoendoscopic Single-site
17%
Survival Outcomes
17%
Thrombectomy
17%
Clinical T2
10%
Renal Vein Thrombus
9%
Laparoscopic Partial Nephrectomy
9%
Multiport
9%
Renal Tumor
9%
Overall Survival
9%
Metastatic Renal Cell Carcinoma (mRCC)
9%
Multi-signal
8%
Combined Modality Therapy
8%
Pathway Genes
8%
Renal Cryoablation
8%
Oxidative Stress Pathway
8%
Practice Trends
8%
Hereditary Leiomyomatosis
8%
SMG7
8%
Cancer Hospital
8%
Leucine-rich
8%
Erectile Dysfunction
8%
Locoregional
8%
Prostate Cancer Risk
8%
Multi-institutional Study
8%
Preoperative Chemotherapy
8%
Coactivator
8%
Interaction Motif
8%
Patient Survival
8%
Off-label Use
8%
Peroxisome Proliferator-activated Receptor
8%
Regional Lymph Nodes
8%
Repeat Prostate Biopsy
8%
Testicular Germ Cell Tumor
8%
Nuclear Receptor
8%
Urinary Bother
8%
Percutaneous Cryotherapy
8%
Tumor Morphology
8%
Rich Interaction
8%
Hospital Database
8%
Urine Leak
8%
Benign Prostatic Hyperplasia
8%
High-risk Non-muscle-invasive Bladder Cancer
8%
Estimated Glomerular Filtration Rate
8%